Related Experiment Video
Updated: Aug 18, 2025

Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
Published on: January 26, 2018
Acetylation State of Lysine 14 of Histone H3.3 Affects Mutant Huntingtin Induced Pathogenesis
Anikó Faragó1,2, Nóra Zsindely1, Anita Farkas1,2
1Department of Biochemistry and Molecular Biology, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, H-6726 Szeged, Hungary.
Insights
Huntington's Disease (HD) involves gene silencing. Modifying histone H3.3K14 acetylation in a fly model improved HD symptoms, suggesting epigenetic regulation is key for neurodegeneration.
Area of Science:
- Epigenetics
- Neurobiology
- Genetics
Background:
- Huntington's Disease (HD) is a fatal neurodegenerative disorder linked to CAG repeat expansion in the Huntingtin gene.
- Transcriptional dysregulation, partly due to histone acetyltransferase (HAT) inhibition, contributes to HD neurodegeneration.
- Modulating HAT or histone deacetylase (HDAC) activity can alleviate HD pathology.
Purpose of the Study:
- To investigate the role of histone post-translational modifications (PTMs) in HD pathology.
- To determine the phenotype-modifying effects of PTM mimetic mutations of variant histone H3.3 in a Drosophila model of HD.
Main Methods:
- Created transgenic H3.3 with PTM mimetic mutations (K→Q: acetylated; K→R: non-modified; K→M: methylated) at lysine residues K9, K14, and K27.
- Assessed the effects of these mutations on HD phenotypes in Drosophila, including viability, longevity, neurodegeneration, motor activity, and circadian rhythms.
- Examined the interaction of H3.3K14 mutations with Gcn5 (HAT) and Sirt1 (HDAC) in the context of HD.
Main Results:
- H3.3K14Q mutation significantly ameliorated all tested HD phenotypes in Drosophila.
- H3.3K14R mutation exacerbated HD phenotypes.
- H3.3K14Q expression counteracted the detrimental effects of reduced Gcn5 activity and partially mitigated the beneficial effects of Sirt1.
Conclusions:
- The acetylation of H3.3K14, particularly dependent on Gcn5, plays a crucial role in modulating Huntington's Disease pathology.
- Targeting H3.3K14 acetylation represents a potential therapeutic strategy for HD.
Abstract:
Huntington's Disease (HD) is a fatal neurodegenerative disorder caused by the expansion of a polyglutamine-coding CAG repeat in the Huntingtin gene. One of the main causes of neurodegeneration in HD is transcriptional dysregulation that, in part, is caused by the inhibition of histone acetyltransferase (HAT) enzymes. HD pathology can be alleviated by increasing the activity of specific HATs or by inhibiting histone deacetylase (HDAC) enzymes. To determine which histone's post-translational modifications (PTMs) might play crucial roles in HD pathology, we investigated the phenotype-modifying effects of PTM mimetic mutations of variant histone H3.3 in a Drosophila model of HD. Specifically, we studied the mutations (K→Q: acetylated; K→R: non-modified; and K→M: methylated) of lysine residues K9, K14, and K27 of transgenic H3.3. In the case of H3.3K14Q modification, we observed the amelioration of all tested phenotypes (viability, longevity, neurodegeneration, motor activity, and circadian rhythm defects), while H3.3K14R had the opposite effect. H3.3K14Q expression prevented the negative effects of reduced Gcn5 (a HAT acting on H3K14) on HD pathology, while it only partially hindered the positive effects of heterozygous Sirt1 (an HDAC acting on H3K14). Thus, we conclude that the Gcn5-dependent acetylation of H3.3K14 might be an important epigenetic contributor to HD pathology.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Spreading of Chromatin Modifications
Writers
The writer...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Lysosomal Hydrolases
Histone Variants at the Centromere

